Durect and Gilead Collaborate on HIV Therapy - PharmaLive

Durect and Gilead Collaborate on HIV Therapy  PharmaLive

Published: July 22, 2019. By Mark Terry. DURECT Corporation inked a collaboration and license deal with Gilead Sciences to develop and market a long-acting ...